Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood-brain barrier in rodents and primates.
Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood-brain barrier in rodents and primates.
复制标题
腺相关病毒血清型 9 的变体,在啮齿类动物和灵长类动物中具有增强的血脑屏障渗透性。
DOI:
10.1038/s41551-022-00938-7
复制
发表时间:
2022
影响因子:
28.1
通讯作者:
Bei,Fengfeng
中科院分区:
文献类型:
--
作者:
Yao,Yizheng;Wang,Jun;Liu,Yi;Qu,Yuan;Wang,Kaikai;Zhang,Yang;Chang,Yuxin;Yang,Zhi;Wan,Jie;Liu,Junfeng;Nakashima,Hiroshi;Lawler,SeanE;Chiocca,EAntonio;Cho,Choi-Fong;Bei,Fengfeng
The development of gene therapies for the treatment of diseases of the central nervous system has been hindered by the limited availability of adeno-associated viruses (AAVs) that efficiently traverse the blood–brain barrier (BBB). Here, we report the rational design of AAV9 variants displaying cell-penetrating peptides on the viral capsid and the identification of two variants, AAV.CPP.16 and AAV.CPP.21, with improved transduction efficiencies of cells of the central nervous system on systemic delivery (6- to 249-fold across 4 mouse strains and 5-fold in cynomolgus macaques, with respect to the AAV9 parent vector). We also show that the neurotropism of AAV.CPP.16 is retained in young and adult macaques, that this variant displays enhanced transcytosis at the BBB as well as increased efficiency of cellular transduction relative to AAV9, and that it can be used to deliver antitumour payloads in a mouse model of glioblastoma. AAV capsids that can efficiently penetrate the BBB will facilitate the clinical translation of gene therapies aimed at the central nervous system.